Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Behjatolah Karbassi

TitleAssociate Professor
InstitutionUniversity of Arkansas for Medical Sciences
DepartmentPathology, College of Medicine
DivisionPathology Academic
Address308-2 Biomedical Research II
200 South Cedar
Mail Slot # 824
Little Rock AR 72202
Phone501-526-7874
vCardDownload vCard

    Collapse Research 
    Collapse research overview
    My primary research interest is in developing immunotherapeutic strategies to potentiate the anti-cancer immune response by targeting immune suppression within the tumor microenvironment. Central to my approach is the investigation of tumor-associated glycans (TAGs) as therapeutic targets, with a particular emphasis on breast cancer.

    Collapse research activities and funding
    R21CA280448     (Post, Steven; Karbassi, Behjatolah)Jan 1, 2024 - Dec 31, 2026
    NIH/Nat. Cancer Institute
    SR-A as a therapeutic target in breast cancer
    Role: Principal Investigator
         (Karbassi)Jun 16, 2022 - Jun 15, 2023
    UAMS research council, Development Enhancement Awards for Proposals
    Immune Responses to a Carbohydrate Mimetic Peptide Vaccine
    Role: Principle Investigator
         (Karbbassi)Jun 1, 2021 - Jun 30, 2022
    UAMS Medical Research Endowment fund
    Defining Tumor-Associated Glycans on Breast Cancer Cells that are Ligands for Macrophage SR-A
    Role: Principle Investigator
         (Karbassi)Jul 1, 2019 - Jun 30, 2023
    Winthrop P Rockefeller Cancer Institute
    Vaccination of Breast Cancer Patients with P10s-PADRE
    Role: Principle Investigator
         (Karbassi)Jul 1, 2019 - Jun 30, 2021
    Arkansas Bioscience Institute,
    Immune monitoring of vaccinated breast cancer patients
    Role: Principle Investigator
         (Steven Post)Feb 1, 2019 - Dec 31, 2022
    Arkansas Breast cancer Research program
    Role of scavenger receptor-A (SR-A) binding to tumor-associated glycans
    Role: Co-Investigator
         (Tim Chambers)Sep 1, 2017 - Aug 31, 2018
    Arkansas Breast Cancer Research Program.
    Explant models and derived primary cell lines for the discovery and testing of novel therapies for breast cancer.
    Role: Co-Investigator
         (Tim Chambers)Sep 1, 2016 - Aug 31, 2017
    Arkansas Breast Cancer Research Program
    Ex vivo models of breast cancer for the development of novel drug combinations, a pilot study.
    Role: Co-Investigator
    W81XWH-06-1-0542     (KIEBER-EMMONS, THOMAS)Apr 24, 2006 - Nov 23, 2013
    US Department of the Army
    Vaccination of High-Risk Breast Cancer patients with Carbohydrate Mimicking Peptides
    Role: Co-Investigator
    W81XWH-06-1-0542 (BC050157)     (KIEBER-EMMONS, THOMAS)Apr 24, 2006 - May 24, 2011
    US Department of the Army
    Vaccination of High-Risk Breast Cancer patients with Carbohydrate Mimicking Peptides
    Role: Co-Investigator
    P01CA089480     (KIEBER-EMMONS, THOMAS)Sep 1, 2002 - Apr 30, 2006
    NIH/Nat. Cancer Institute - Pass Through: University of Pennsylvania
    Novel Approaches to Cancer Therapy (subcontract w/ Penn State)
    Role: Co-Investigator
    R01AI049092     (KIEBER-EMMONS, THOMAS)Apr 1, 2002 - Mar 31, 2008
    NIH
    Mimotope Conversion of HIV-1 Carbohydrate Antigens
    Role: Co-Investigator

    Collapse Outreach 

    Collapse Bibliographic 
    Collapse additional bibliographic sources
    The links below are provided by the researcher to provide access to external online bibliographies that they keep independently from the Profiles System.
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions. Don't see publications published under other names? Login to add alternative names.
    List All   |   Timeline
    1. Monzavi-Karbassi B, Kelly T, Post SR. The Tumor Microenvironment and Immune Response in Breast Cancer. Int J Mol Sci. 2024 Jan 11; 25(2). PMID: 38255987.
      View in: PubMed
    2. Li W, Twaddle NC, Spray B, Nounamo B, Monzavi-Karbassi B, Hakkak R. Feeding Soy Protein Concentrates with Low and High Isoflavones Alters 9 and 18 Weeks Serum Isoflavones and Inflammatory Protein Levels in Lean and Obese Zucker Rats. J Med Food. 2023 Feb; 26(2):120-127. PMID: 36720082.
      View in: PubMed
    3. Nounamo B, Jousheghany F, Siegel ER, Post SR, Kelly T, Ferrone S, Kieber-Emmons T, Monzavi-Karbassi B. VT68.2: An Antibody to Chondroitin Sulfate Proteoglycan 4 (CSPG4) Displays Reactivity against a Tumor-Associated Carbohydrate Antigen. Int J Mol Sci. 2023 Jan 28; 24(3). PMID: 36768830.
      View in: PubMed
    4. Pashov A, Murali R, Makhoul I, Karbassi B, Kieber-Emmons T. Harnessing Antibody Polyspecificity for Cancer Immunotherapy. Monoclon Antib Immunodiagn Immunother. 2022 Oct; 41(5):290-300. PMID: 36306515.
      View in: PubMed
    5. Makhoul I, Ibrahim SM, Abu-Rmaileh M, Jousheghany F, Siegel ER, Rogers LJ, Lee JJ, Pina-Oviedo S, Post GR, Beck JT, Kieber-Emmons T, Monzavi-Karbassi B. P10s-PADRE vaccine combined with neoadjuvant chemotherapy in ER-positive breast cancer patients induces humoral and cellular immune responses. Oncotarget. 2021 Oct 26; 12(22):2252-2265. PMID: 34733416.
      View in: PubMed
    6. Hernandez Puente CV, Hsu PC, Rogers LJ, Jousheghany F, Siegel E, Kadlubar SA, Beck JT, Makhoul I, Hutchins LF, Kieber-Emmons T, Monzavi-Karbassi B. Association of DNA-Methylation Profiles With Immune Responses Elicited in Breast Cancer Patients Immunized With a Carbohydrate-Mimicking Peptide: A Pilot Study. Front Oncol. 2020; 10:879. PMID: 32582547.
      View in: PubMed
    7. Behrens A, Jousheghany F, Yao-Borengasser A, Siegel ER, Kieber-Emmons T, Monzavi-Karbassi B. Carbohydrate (Chondroitin 4) Sulfotransferase-11-Mediated Induction of Epithelial-Mesenchymal Transition and Generation of Cancer Stem Cells. Pharmacology. 2020; 105(5-6):246-259. PMID: 32344408.
      View in: PubMed
    8. Urbaniak A, Jousheghany F, Pi?a-Oviedo S, Yuan Y, Majcher-Uchanska U, Klejborowska G, Moorjani A, Monzavi-Karbassi B, Huczynski A, Chambers TC. Carbamate derivatives of colchicine show potent activity towards primary acute lymphoblastic leukemia and primary breast cancer cells-in vitro and ex vivo study. J Biochem Mol Toxicol. 2020 Jun; 34(6):e22487. PMID: 32141170.
      View in: PubMed
    9. Urbaniak A, Jousheghany F, Yuan Y, Pi?a-Oviedo S, Huczynski A, Delgado M, Kieber-Emmons T, Monzavi-Karbassi B, Chambers TC. The response of phyllodes tumor of the breast to anticancer therapy: An in vitro and ex vivo study. Oncol Lett. 2019 Nov; 18(5):5097-5106. PMID: 31612021.
      View in: PubMed
    10. Pashov A, Hernandez Puente CV, Ibrahim SM, Monzavi-Karbassi B, Makhoul I, Kieber-Emmons T. Thinking Cancer. Monoclon Antib Immunodiagn Immunother. 2018 Jun; 37(3):117-125. PMID: 29939836.
      View in: PubMed
    11. Hutchins LF, Makhoul I, Emanuel PD, Pennisi A, Siegel ER, Jousheghany F, Guo X, Pashov AD, Monzavi-Karbassi B, Kieber-Emmons T. Targeting tumor-associated carbohydrate antigens: a phase I study of a carbohydrate mimetic-peptide vaccine in stage IV breast cancer subjects. Oncotarget. 2017 Nov 17; 8(58):99161-99178. PMID: 29228761.
      View in: PubMed
    12. Kieber-Emmons T, Monzavi-Karbassi B, Hutchins LF, Pennisi A, Makhoul I. Harnessing benefit from targeting tumor associated carbohydrate antigens. Hum Vaccin Immunother. 2017 02; 13(2):323-331. PMID: 27929800.
      View in: PubMed
    13. Kieber-Emmons T, Makhoul I, Pennisi A, Siegel ER, Emanuel PD, Monzavi-Karbassi B, Steplewski Z, Beck JT, Hutchins LF. Managing Expectations in the Transition to Proof of Concept Studies. Rev Recent Clin Trials. 2017; 12(2):111-123. PMID: 28325150.
      View in: PubMed
    14. Monzavi-Karbassi B, Jousheghany F, Kieber-Emmons T. Tumor-associated Glycans and Tregs in Immunogenicity of an Autologous Cell-based Vaccine. Immunol Invest. 2016 Nov; 45(8):746-758. PMID: 27759476.
      View in: PubMed
    15. Monzavi-Karbassi B, Siegel ER, Medarametla S, Makhoul I, Kieber-Emmons T. Breast cancer survival disparity between African American and Caucasian women in Arkansas: A race-by-grade analysis. Oncol Lett. 2016 Aug; 12(2):1337-1342. PMID: 27446434.
      View in: PubMed
    16. Monzavi-Karbassi B, Gentry R, Kaur V, Siegel ER, Jousheghany F, Medarametla S, Fuhrman BJ, Safar AM, Hutchins LF, Kieber-Emmons T. Pre-diagnosis blood glucose and prognosis in women with breast cancer. Cancer Metab. 2016; 4:7. PMID: 27054036.
      View in: PubMed
    17. Yao-Borengasser A, Monzavi-Karbassi B, Hedges RA, Rogers LJ, Kadlubar SA, Kieber-Emmons T. Adipocyte hypoxia promotes epithelial-mesenchymal transition-related gene expression and estrogen receptor-negative phenotype in breast cancer cells. Oncol Rep. 2015 Jun; 33(6):2689-94. PMID: 25823469.
      View in: PubMed
    18. Herman D, Leakey TI, Behrens A, Yao-Borengasser A, Cooney CA, Jousheghany F, Phanavanh B, Siegel ER, Safar AM, Korourian S, Kieber-Emmons T, Monzavi-Karbassi B. CHST11 gene expression and DNA methylation in breast cancer. Int J Oncol. 2015 Mar; 46(3):1243-51. PMID: 25586191.
      View in: PubMed
    19. Kieber-Emmons T, Pennisi A, Lane A, Siegel E, Cannon M, Monzavi-Karbassi B, Makhoul I. Defining and managing expectations for early immunotherapy cancer trials. Rev Recent Clin Trials. 2015; 10(1):47-60. PMID: 25723736.
      View in: PubMed
    20. Makhoul I, Hutchins L, Emanuel PD, Pennisi A, Siegel E, Jousheghany F, Monzavi-Karbassi B, Kieber-Emmons T. Moving a Carbohydrate Mimetic Peptide into the clinic. Hum Vaccin Immunother. 2015; 11(1):37-44. PMID: 25483513.
      View in: PubMed
    21. Kieber-Emmons T, Saha S, Pashov A, Monzavi-Karbassi B, Murali R. Carbohydrate-mimetic peptides for pan anti-tumor responses. Front Immunol. 2014; 5:308. PMID: 25071769.
      View in: PubMed
    22. Monzavi-Karbassi B, Pashov A, Kieber-Emmons T. Tumor-Associated Glycans and Immune Surveillance. Vaccines (Basel). 2013 Jun 17; 1(2):174-203. PMID: 26343966.
      View in: PubMed
    23. Kieber-Emmons T, Monzavi-Karbassi B, Pashov A, Saha S, Murali R, Kohler H. The promise of the anti-idiotype concept. Front Oncol. 2012; 2:196. PMID: 23267437.
      View in: PubMed
    24. Hennings L, Artaud C, Jousheghany F, Monzavi-Karbassi B, Pashov A, Kieber-Emmons T. Carbohydrate mimetic peptides augment carbohydrate-reactive immune responses in the absence of immune pathology. Cancers (Basel). 2011 Nov 11; 3(4):4151-69. PMID: 24213131.
      View in: PubMed
    25. Cooney CA, Jousheghany F, Yao-Borengasser A, Phanavanh B, Gomes T, Kieber-Emmons AM, Siegel ER, Suva LJ, Ferrone S, Kieber-Emmons T, Monzavi-Karbassi B. Chondroitin sulfates play a major role in breast cancer metastasis: a role for CSPG4 and CHST11 gene expression in forming surface P-selectin ligands in aggressive breast cancer cells. Breast Cancer Res. 2011 Jun 09; 13(3):R58. PMID: 21658254.
      View in: PubMed
    26. Kieber-Emmons AM, Jousheghany F, Monzavi-Karbassi B. Breast Cancer - Focusing Tumor Microenvironment, Stem cells and Metastasis. On the Role of Cell Surface Chondroitin Sulfates and their Core Proteins in Breast Cancer Metastasis. 2011.
    27. Pashov A, Monzavi-Karbassi B, Kieber-Emmons T. Glycan mediated immune responses to tumor cells. Hum Vaccin. 2011 Jan-Feb; 7 Suppl:156-65. PMID: 21321481.
      View in: PubMed
    28. Monzavi-Karbassi B, Hine RJ, Stanley JS, Ramani VP, Carcel-Trullols J, Whitehead TL, Kelly T, Siegel ER, Artaud C, Shaaf S, Saha R, Jousheghany F, Henry-Tillman R, Kieber-Emmons T. Fructose as a carbon source induces an aggressive phenotype in MDA-MB-468 breast tumor cells. Int J Oncol. 2010 Sep; 37(3):615-22. PMID: 20664930.
      View in: PubMed
    29. Pashov A, Monzavi-Karbassi B, Raghava GP, Kieber-Emmons T. Bridging innate and adaptive antitumor immunity targeting glycans. J Biomed Biotechnol. 2010; 2010:354068. PMID: 20617150.
      View in: PubMed
    30. Pashov A, Garimalla S, Monzavi-Karbassi B, Kieber-Emmons T. Carbohydrate targets in HIV vaccine research: lessons from failures. Immunotherapy. 2009 Sep; 1(5):777-94. PMID: 20636023.
      View in: PubMed
    31. Pashov A, Monzavi-Karbassi B, Kieber-Emmons T. Immune surveillance and immunotherapy: lessons from carbohydrate mimotopes. Vaccine. 2009 May 26; 27(25-26):3405-15. PMID: 19200843.
      View in: PubMed
    32. Korourian S, Siegel E, Kieber-Emmons T, Monzavi-Karbassi B. Expression analysis of carbohydrate antigens in ductal carcinoma in situ of the breast by lectin histochemistry. BMC Cancer. 2008 May 14; 8:136. PMID: 18479514.
      View in: PubMed
    33. Pashov A, Monzavi-Karbassi B, Chow M, Cannon M, Kieber-Emmons T. Immune surveillance as a rationale for immunotherapy? Hum Vaccin. 2007 Sep-Oct; 3(5):224-8. PMID: 17660717.
      View in: PubMed
    34. Monzavi-Karbassi B, Stanley JS, Hennings L, Jousheghany F, Artaud C, Shaaf S, Kieber-Emmons T. Chondroitin sulfate glycosaminoglycans as major P-selectin ligands on metastatic breast cancer cell lines. Int J Cancer. 2007 Mar 15; 120(6):1179-91. PMID: 17154173.
      View in: PubMed
    35. Monzavi-Karbassi B, Hennings LJ, Artaud C, Liu T, Jousheghany F, Pashov A, Murali R, Hutchins LF, Kieber-Emmons T. Preclinical studies of carbohydrate mimetic peptide vaccines for breast cancer and melanoma. Vaccine. 2007 Apr 20; 25(16):3022-31. PMID: 17303294.
      View in: PubMed
    36. Pashov A, Monzavi-Karbassi B, Raghava G, Kieber-Emmons T. Peptide mimotopes as prototypic templates of broad-spectrum surrogates of carbohydrate antigens for cancer vaccination. Crit Rev Immunol. 2007; 27(3):247-70. PMID: 18197820.
      View in: PubMed
    37. Pashov AD, Plaxco J, Kaveri SV, Monzavi-Karbassi B, Harn D, Kieber-Emmons T. Multiple antigenic mimotopes of HIV carbohydrate antigens: relating structure and antigenicity. J Biol Chem. 2006 Oct 06; 281(40):29675-83. PMID: 16899462.
      View in: PubMed
    38. Monzavi-Karbassi B, Pashov A, Jousheghany F, Artaud C, Kieber-Emmons T. Evaluating strategies to enhance the anti-tumor immune response to a carbohydrate mimetic peptide vaccine. Int J Mol Med. 2006 Jun; 17(6):1045-52. PMID: 16685414.
      View in: PubMed
    39. Carcel-Trullols J, Stanley JS, Saha R, Shaaf S, Bendre MS, Monzavi-Karbassi B, Suva LJ, Kieber-Emmons T. Characterization of the glycosylation profile of the human breast cancer cell line, MDA-231, and a bone colonizing variant. Int J Oncol. 2006 May; 28(5):1173-83. PMID: 16596233.
      View in: PubMed
    40. Monzavi-Karbassi B, Whitehead TL, Jousheghany F, Artaud C, Hennings L, Shaaf S, Slaughter A, Korourian S, Kelly T, Blaszczyk-Thurin M, Kieber-Emmons T. Deficiency in surface expression of E-selectin ligand promotes lung colonization in a mouse model of breast cancer. Int J Cancer. 2005 Nov 10; 117(3):398-408. PMID: 15906360.
      View in: PubMed
    41. Whitehead TL, Karbassi B, Kieber-Emmons T. 1H-NMR metabonomics analysis of sera differentiates between mammary tumor-bearing mice and healthy controls. Metabolomics. 2005; E-publish.
    42. Whitehead TL, Monzavi-Karbassi B, Jousheghany F, Artaud C, Elbein A, Kieber-Emmons T. 1H-NMR metabolic markers of malignancy correlate with spontaneous metastases in a murine mammary tumor model. Int J Oncol. 2005 Jul; 27(1):257-63. PMID: 15942667.
      View in: PubMed
    43. Pashov A, Canziani G, Monzavi-Karbassi B, Kaveri SV, Macleod S, Saha R, Perry M, Vancott TC, Kieber-Emmons T. Antigenic properties of peptide mimotopes of HIV-1-associated carbohydrate antigens. J Biol Chem. 2005 Aug 12; 280(32):28959-65. PMID: 15955803.
      View in: PubMed
    44. Monzavi-Karbassi B, Artaud C, Jousheghany F, Hennings L, Carcel-Trullols J, Shaaf S, Korourian S, Kieber-Emmons T. Reduction of spontaneous metastases through induction of carbohydrate cross-reactive apoptotic antibodies. J Immunol. 2005 Jun 01; 174(11):7057-65. PMID: 15905549.
      View in: PubMed
    45. Pashov A, Canziani G, Macleod S, Plaxco J, Monzavi-Karbassi B, Kieber-Emmons T. Targeting carbohydrate antigens in HIV vaccine development. Vaccine. 2005 Mar 18; 23(17-18):2168-75. PMID: 15755589.
      View in: PubMed
    46. Monzavi-Karbassi B, Luo P, Jousheghany F, Torres-Qui?ones M, Cunto-Amesty G, Artaud C, Kieber-Emmons T. A mimic of tumor rejection antigen-associated carbohydrates mediates an antitumor cellular response. Cancer Res. 2004 Mar 15; 64(6):2162-6. PMID: 15026358.
      View in: PubMed
    47. Agadjanyan MG, Chattergoon MA, Holterman MJ, Monzavi-Karbassi B, Kim JJ, Dentchev T, Wilson D, Ayyavoo V, Montaner LJ, Kieber-Emmons T, Sekaly RP, Weiner DB. Costimulatory molecule immune enhancement in a plasmid vaccine model is regulated in part through the Ig constant-like domain of CD80/86. J Immunol. 2003 Oct 15; 171(8):4311-9. PMID: 14530356.
      View in: PubMed
    48. Monzavi-Karbassi B, Luo P, Cunto-Amesty G, Jousheghany F, Pashov A, Weissman D, Kieber-Emmons T. Fucosylated lactosamines participate in adhesion of HIV-1 envelope glycoprotein to dendritic cells. Arch Virol. 2004 Jan; 149(1):75-91. PMID: 14689277.
      View in: PubMed
    49. Cunto-Amesty G, Monzavi-Karbassi B, Luo P, Jousheghany F, Kieber-Emmons T. Strategies in cancer vaccines development. Int J Parasitol. 2003 May; 33(5-6):597-613. PMID: 12782058.
      View in: PubMed
    50. Cunto-Amesty G, Luo P, Monzavi-Karbassi B, Lees A, Alexander J, del Guercio MF, Nahm MH, Artaud C, Stanley J, Kieber-Emmons T. Peptide mimotopes as prototypic templates of broad-spectrum surrogates of carbohydrate antigens. Cell Mol Biol (Noisy-le-grand). 2003 Mar; 49(2):245-54. PMID: 12887105.
      View in: PubMed
    51. Monzavi-Karbassi B, Shamloo S, Kieber-Emmons M, Jousheghany F, Luo P, Lin KY, Cunto-Amesty G, Weiner DB, Kieber-Emmons T. Priming characteristics of peptide mimotopes of carbohydrate antigens. Vaccine. 2003 Jan 30; 21(7-8):753-60. PMID: 12531355.
      View in: PubMed
    52. Monzavi-Karbassi B, Cunto-Amesty G, Luo P, Kieber-Emmons T. Peptide mimotopes as surrogate antigens of carbohydrates in vaccine discovery. Trends Biotechnol. 2002 May; 20(5):207-14. PMID: 11943376.
      View in: PubMed
    53. Monzavi-Karbassi B, Cunto-Amesty G, Luo P, Kieber-Emmons T. Use of surrogate antigens as vaccines against cancer. Hybrid Hybridomics. 2002 Apr; 21(2):103-9. PMID: 12031099.
      View in: PubMed
    54. Monzavi-Karbassi B, Cunto-Amesty G, Luo P, Shamloo S, Blaszcyk-Thurin M, Kieber-Emmons T. Immunization with a carbohydrate mimicking peptide augments tumor-specific cellular responses. Int Immunol. 2001 Nov; 13(11):1361-71. PMID: 11675368.
      View in: PubMed
    55. Monzavi-Karbassi B, Cunto-Amesty G, Luo P, Lees A, Kieber-Emmons T. Immunological characterization of peptide mimetics of carbohydrate antigens in vaccine design strategies. Biologicals. 2001 Sep-Dec; 29(3-4):249-57. PMID: 11851324.
      View in: PubMed
    56. Cunto-Amesty G, Dam TK, Luo P, Monzavi-Karbassi B, Brewer CF, Van Cott TC, Kieber-Emmons T. Directing the immune response to carbohydrate antigens. J Biol Chem. 2001 Aug 10; 276(32):30490-8. PMID: 11384987.
      View in: PubMed
    57. Cunto-Amesty G, Luo P, Monzavi-Karbassi B, Lees A, Kieber-Emmons T. Exploiting molecular mimicry to broaden the immune response to carbohydrate antigens for vaccine development. Vaccine. 2001 Mar 21; 19(17-19):2361-8. PMID: 11257361.
      View in: PubMed
    58. Monzavi-Karbassi B, Kieber-Emmons T. Current concepts in cancer vaccine strategies. Biotechniques. 2001 Jan; 30(1):170-2, 174, 176 passim. PMID: 11196309.
      View in: PubMed
    59. Cunto-Amesty G, Luo P, Monzavi-Karbassi B, Kieber-Emmons T. Exploiting molecular mimicry: defining rules of the game. Int Rev Immunol. 2001; 20(2):157-80. PMID: 11878763.
      View in: PubMed
    60. Kieber-Emmons T, Monzavi-Karbassi B, Wang B, Luo P, Weiner DB. Cutting edge: DNA immunization with minigenes of carbohydrate mimotopes induce functional anti-carbohydrate antibody response. J Immunol. 2000 Jul 15; 165(2):623-7. PMID: 10878332.
      View in: PubMed
    61. Agadjanyan MG, Kim JJ, Trivedi N, Wilson DM, Monzavi-Karbassi B, Morrison LD, Nottingham LK, Dentchev T, Tsai A, Dang K, Chalian AA, Maldonado MA, Williams WV, Weiner DB. CD86 (B7-2) can function to drive MHC-restricted antigen-specific CTL responses in vivo. J Immunol. 1999 Mar 15; 162(6):3417-27. PMID: 10092797.
      View in: PubMed
    62. Piruzian ES, Monzavi-Karbassi B, Darbinian NS, Goldenkova IV, Kobets NS, Mochulsky AV. The use of a thermostable beta-glucanase gene from Clostridium thermocellum as a reporter gene in plants. Mol Gen Genet. 1998 Mar; 257(5):561-7. PMID: 9563842.
      View in: PubMed
    63. Piruzian ES, Monzavi-Karbassi B, Darbinian NS, Goldenkova IV, Kobets NS, Mochulsky AV. The use of a thermostable beta-glucanase gene from Clostridium thermocellum as a reporter gene in plants. Mol Gen Genet. 1998; 257(5):561 - 567.
    Karbassi's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (273) concept(s)
    _
    Co-Authors Expand Description
    See all (8) people
    _
    Similar People Expand Description
    See all (32) people
    _
    Same Department Expand Description
    Search Department